|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2003-9-30
|
|
pubmed:abstractText |
Although the renin-angiotensin and the beta-adrenergic systems are interrelated, a direct interaction between beta-adrenergic receptors (betaARs) and angiotensin II type 1 receptors (AT1Rs) has not been identified.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Heterotrimeric GTP-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol,
http://linkedlifedata.com/resource/pubmed/chemical/Macromolecular Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Propranolol,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Angiotensin,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Valine,
http://linkedlifedata.com/resource/pubmed/chemical/valsartan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
30
|
|
pubmed:volume |
108
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1611-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12963634-Adrenergic beta-Antagonists,
pubmed-meshheading:12963634-Angiotensin II,
pubmed-meshheading:12963634-Angiotensin Receptor Antagonists,
pubmed-meshheading:12963634-Animals,
pubmed-meshheading:12963634-Binding, Competitive,
pubmed-meshheading:12963634-COS Cells,
pubmed-meshheading:12963634-Cell Line,
pubmed-meshheading:12963634-Cells, Cultured,
pubmed-meshheading:12963634-Female,
pubmed-meshheading:12963634-Heart Rate,
pubmed-meshheading:12963634-Heterotrimeric GTP-Binding Proteins,
pubmed-meshheading:12963634-Humans,
pubmed-meshheading:12963634-Isoproterenol,
pubmed-meshheading:12963634-Macromolecular Substances,
pubmed-meshheading:12963634-Mice,
pubmed-meshheading:12963634-Mice, Inbred C57BL,
pubmed-meshheading:12963634-Myocardial Contraction,
pubmed-meshheading:12963634-Myocytes, Cardiac,
pubmed-meshheading:12963634-Propranolol,
pubmed-meshheading:12963634-Receptor, Angiotensin, Type 1,
pubmed-meshheading:12963634-Receptors, Adrenergic, beta,
pubmed-meshheading:12963634-Receptors, Angiotensin,
pubmed-meshheading:12963634-Signal Transduction,
pubmed-meshheading:12963634-Tetrazoles,
pubmed-meshheading:12963634-Valine
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.
|
|
pubmed:affiliation |
Department of Medicine, Duke University Medical Center, Durham, NC, 27710, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
